Literature DB >> 2693011

Pancreatic diabetes mellitus.

R J Sjoberg1, G S Kidd.   

Abstract

Diabetes mellitus caused by pancreatic exocrine disease is a unique clinical and metabolic form of diabetes. The diagnosis of pancreatic diabetes caused by chronic pancreatitis may be elusive because it is occasionally painless and often not accompanied by clinical malabsorption until after hyperglycemia occurs. Diabetic patients with pancreatic calcification or clinically demonstrable pancreatic exocrine dysfunction will manifest the unique aspects of pancreatic diabetes described herein. Like other forms of diabetes, the primary hormonal abnormality in pancreatic diabetes is decreased insulin secretion. Patients with this disorder are unique in that they have low glucagon levels that respond abnormally to several physiological stimuli, blunted epinephrine responses to insulin-induced hypoglycemia, and malabsorption. In addition, they often have concomitant alcohol abuse with hepatic disease and poor nutrition. These characteristics result in increased levels of circulating gluconeogenic amino acids, decreased insulin requirements, a resistance to ketosis, low cholesterol levels, an increased risk of hypoglycemia while on insulin therapy, and the clinical impression of brittle diabetes. Retinopathy occurs at a rate equal to that of insulin-dependent diabetes but may be less severe in degree. Other complications of pancreatic diabetes have been less well studied but may be expected to be seen more frequently as these patients survive longer. The characteristics of pancreatic diabetes suggest that a conservative approach be taken in regard to intensive insulin therapy and tight blood glucose control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693011     DOI: 10.2337/diacare.12.10.715

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

1.  Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies.

Authors:  A Wiberg; A Granstam; S Ingvast; T Härkönen; M Knip; O Korsgren; O Skog
Journal:  Clin Exp Immunol       Date:  2015-10-06       Impact factor: 4.330

2.  Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis.

Authors:  T Nakamura; K Imamura; K Takebe; A Terada; Y Arai; Y Tandoh; N Yamada; M Ishii; K Machida; T Suda
Journal:  Int J Pancreatol       Date:  1996-12

3.  Higher mortality of patients on haemodialysis with pancreatic diabetes compared to type 2-diabetes.

Authors:  Gert Bodlaj; Georg Biesenbach
Journal:  Diabetol Metab Syndr       Date:  2012-03-23       Impact factor: 3.320

Review 4.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

5.  The current managements of pancreatic diabetes in Japan.

Authors:  Ken Kawabe; Tetsuhide Ito; Hisato Igarashi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2009-01-07

6.  Chronic Pancreatitis and Diabetes Mellitus.

Authors:  Yu Kuei Lin; Philip C Johnston; Karla Arce; Betul A Hatipoglu
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 7.  Treatment of pancreatic exocrine deficiency.

Authors:  Martin Sarner
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

8.  Glycemic Predictors of Insulin Independence After Total Pancreatectomy With Islet Autotransplantation.

Authors:  Michael Quartuccio; Erica Hall; Vikesh Singh; Martin A Makary; Kenzo Hirose; Niraj Desai; Christi Walsh; Daniel Warren; Zhaoli Sun; Ellen Stein; Rita R Kalyani
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

9.  Clinical aspects of pancreatogenic diabetes secondary to hereditary pancreatitis.

Authors:  Marcio Garrison Dytz; Pedro Arthur Hamamoto Marcelino; Olga de Castro Santos; Lenita Zajdenverg; Flavia Lucia Conceição; Tânia Maria Ortiga-Carvalho; Melanie Rodacki
Journal:  Diabetol Metab Syndr       Date:  2017-01-13       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.